Profit taking sinks Celator Pharmaceuticals

Profit taking weighed down shares of Celator Pharmaceuticals Inc. (Nasdaq: CPXX) $1.85 to close at $10.63.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.